A trans-acting tRNA-embedded ribozyme targeted to HIV-1 RNA is flanked by cis-acting ribozymes at both its 5 ’ and its 3 ’ end so that, upon transcription, the trans-acting ribozyme is trimmed at both its 5 ’ and its 3 ’ end, with resultant liberation of a small tRNA-embedded ribozyme. The trans-acting ribozymes targeted to a different site in HIV-1 RNA were expressed under the control of the SR promoter and were examined in cell culture in a co-transfection transient assay with an HIV-1 infectious molecular clone, pNL4-3, for their ability to suppress HIV-1 replication. Although the extent of inhibition depended on the target site, all constructs caused significant inhibition of the HIV-1 p24 antigen production in culture supernatant. The ...
HIV-1 is the causative agent in AIDS, the world's fourth most frequent cause of death. HIV is a retr...
AbstractRibozymes are catalytic RNAs that offer several advantages as specific therapeutic genes aga...
The length requirements of the antisense portion of hammerhead ribozymes for efficacy in living cell...
grantor: University of TorontoRibozymes are small, catalytic RNA molecules which possess e...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
RNA molecules with enzymatic activity (ribozymes) targeted to the genome of HIV-1 were developed and...
RNA molecules with enzymatic activity (ribozymes) targeted to the genome of HIV-1 were developed and...
Self-cleaving RNAs (ribozymes) can be engineered to cleave target RNAs of choice in a sequence-speci...
Self-cleaving RNAs (ribozymes) can be engineered to cleave target RNAs of choice in a sequence-speci...
Ribozymes are catalytic RNAs that offer several advantages as specific therapeutic genes against hum...
A hammerhead ribozyme targeted against the HIV-1 env coding region was expressed as part of the anti...
Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that ef...
Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that ef...
HIV-1 is the causative agent in AIDS, the world's fourth most frequent cause of death. HIV is a retr...
AbstractRibozymes are catalytic RNAs that offer several advantages as specific therapeutic genes aga...
The length requirements of the antisense portion of hammerhead ribozymes for efficacy in living cell...
grantor: University of TorontoRibozymes are small, catalytic RNA molecules which possess e...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene...
RNA molecules with enzymatic activity (ribozymes) targeted to the genome of HIV-1 were developed and...
RNA molecules with enzymatic activity (ribozymes) targeted to the genome of HIV-1 were developed and...
Self-cleaving RNAs (ribozymes) can be engineered to cleave target RNAs of choice in a sequence-speci...
Self-cleaving RNAs (ribozymes) can be engineered to cleave target RNAs of choice in a sequence-speci...
Ribozymes are catalytic RNAs that offer several advantages as specific therapeutic genes against hum...
A hammerhead ribozyme targeted against the HIV-1 env coding region was expressed as part of the anti...
Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that ef...
Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that ef...
HIV-1 is the causative agent in AIDS, the world's fourth most frequent cause of death. HIV is a retr...
AbstractRibozymes are catalytic RNAs that offer several advantages as specific therapeutic genes aga...
The length requirements of the antisense portion of hammerhead ribozymes for efficacy in living cell...